Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sammy A. Barkal"'
Autor:
Ameen A. Salahudeen, Jose A. Seoane, Kanako Yuki, Amanda T. Mah, Amber R. Smith, Kevin Kolahi, Sean M. De la O, Daniel J. Hart, Jie Ding, Zhicheng Ma, Sammy A. Barkal, Navika D. Shukla, Chuck H. Zhang, Michael A. Cantrell, Arpit Batish, Tatsuya Usui, David E. Root, William C. Hahn, Christina Curtis, Calvin J. Kuo
Publikováno v:
Cell Reports, Vol 42, Iss 11, Pp 113355- (2023)
Summary: Somatic copy number gains are pervasive across cancer types, yet their roles in oncogenesis are insufficiently evaluated. This inadequacy is partly due to copy gains spanning large chromosomal regions, obscuring causal loci. Here, we employe
Externí odkaz:
https://doaj.org/article/266edeeec93f49ce89efe1c759020698
Autor:
Chuck Zhang, Sammy A. Barkal, Jie Ding, William C. Hahn, Daniel J. Hart, Arpit Batish, Christina Curtis, Tatsuya Usui, Zhicheng Ma, Navika D. Shukla, David E. Root, Ameen A. Salahudeen, Calvin J. Kuo, Kevin S. Kolahi, Sean M. de la O, Michael A. Cantrell, Amanda T. Mah, Amber R. Smith, Kanako Yuki, Jose A. Seoane
SUMMARYSomatic copy number gains are pervasive in many cancer types, yet their roles in oncogenesis are often poorly explored. This lack of understanding is in part due to broad extensions of copy gains across cancer genomes spanning large chromosoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be58e7f0c65a67ccbb69f0778a1c09fe
https://doi.org/10.1101/2021.10.05.463147
https://doi.org/10.1101/2021.10.05.463147
Autor:
Richard I. Sherwood, Sammy A Barkal, Sannie J. Culbertson, Sophia Zhang, Heysol C Bermudez-Cabrera, Max W. Shen, Benjamin Holmes, David K. Gifford
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Nature Communications
Nature Communications
Mutational outcomes following CRISPR-Cas9-nuclease cutting in mammalian cells have recently been shown to be predictable and, in certain cases, skewed toward single genotypes. However, the ability to control these outcomes remains limited, especially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e49ed019225d0508ad5181b877277d0
https://doi.org/10.1038/s41467-021-25415-8
https://doi.org/10.1038/s41467-021-25415-8
Autor:
Marisa C Hamilton, Minja Velimirovic, Grace Hui Ting Yeo, Sammy A Barkal, Miha Sovrovic, Maggie S Chen, James D. Fife, Benyapa Khowpinitchai, Larissa C. Zanetti, Ersin Akinci, Lin Lin, Rikita Jodhani, Callie J Donahue, Minsun Cha, Richard I. Sherwood, Philip A. Cole, Nam Chu, Robert A. Davey, Christopher A. Cassa, Heysol C Bermudez-Cabrera
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
The adenosine analogue remdesivir has emerged as a frontline antiviral treatment for SARS-CoV-2, with preliminary evidence that it reduces the duration and severity of illness1. Prior clinical studies have identified adverse events1,2, and remdesivir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eb88bab26c658dee707769080085330
https://doi.org/10.1101/2020.08.27.270819
https://doi.org/10.1101/2020.08.27.270819
Autor:
Sammy A. Barkal, Jason Hatakeyama, Layla J. Barkal, Venkatesh Krishnan, Rachel E. Brewer, Oliver Dorigo, Balyn W. Zaro, Amira A. Barkal, Maxim Markovic, Irving L. Weissman, Mark Kowarsky
Publikováno v:
Nature, vol 572, iss 7769
Nature
Nature
Ovarian cancer and triple-negative breast cancer are among the most lethal diseases affecting women, with few targeted therapies and high rates of metastasis. Cancer cells are capable of evading clearance by macrophages through the overexpression of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb0ded133c4538a65b26afa28f71cc5f
https://escholarship.org/uc/item/2q04s1s6
https://escholarship.org/uc/item/2q04s1s6